iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totalling 146,800 shares, an increase of 321.8% from the September 30th total of 34,800 shares. Based on an average daily volume of 1,830,000 shares, the short-interest ratio is presently 0.1 days. Currently, 1.6% of the shares of the stock are short sold.
iCoreConnect Trading Down 7.4 %
Shares of iCoreConnect stock traded down $0.02 on Friday, hitting $0.26. 250,418 shares of the company’s stock traded hands, compared to its average volume of 5,866,547. The company has a fifty day moving average of $0.44 and a two-hundred day moving average of $0.76. The company has a market capitalization of $3.16 million, a price-to-earnings ratio of -0.09 and a beta of 0.54. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.11 and a quick ratio of 0.11. iCoreConnect has a one year low of $0.25 and a one year high of $3.20.
iCoreConnect (NASDAQ:ICCT – Get Free Report) last announced its quarterly earnings results on Friday, August 16th. The company reported ($1.10) earnings per share for the quarter. iCoreConnect had a negative net margin of 260.79% and a negative return on equity of 614.22%. The company had revenue of $3.09 million during the quarter.
About iCoreConnect
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
Featured Articles
- Five stocks we like better than iCoreConnect
- 3 Warren Buffett Stocks to Buy Now
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 Ways To Invest In Coffee, Other Than Drinking It
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.